Just a quick update on Valeant Pharma, which apparently Bill Ackman has nearly 12,000,000 shares of (at much, much higher prices) – – major trendline break means basically there is no limit to how low this can go (excepting for $0.00).

The good news for everyone is that those Wall Street analysts once again totally earned their seven-figure salaries by helping investors near and far avoid this debacle with their spot-on “short every share you can get!” rating. Oh, wait……

Print Friendly, PDF & Email